Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Proteon Therapeutics has announced that a key patent has been issued by the European patent office, which covers the use of a class of proteins known as elastases for dilating arteries and veins in humans.
Subscribe to our email newsletter
Timothy Noyes, president and CEO of Proteon, said: “The issuance of this patent further strengthens and broadens Proteon’s elastase vasodilation franchise. With this patent in hand, Proteon Therapeutics can continue the global development of PRT-201, our lead drug candidate.”